Growing body of evidence confirms MINIject is safe and effective with results sustained over time
Read more →
http://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.png
0
0
Katherin Awad
http://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.png
Katherin Awad2020-11-16 08:45:302020-11-16 08:25:33iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trialPooled data confirm excellent safety and efficacy profile with very low rate of reintervention
Read more →
http://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.png
0
0
Katherin Awad
http://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.png
Katherin Awad2020-09-29 08:01:402020-10-01 14:31:10Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patientsTwo-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment.
Read more →
http://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.png
0
0
Katherin Awad
http://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.png
Katherin Awad2020-04-29 08:00:342020-10-01 14:30:28First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma
Scroll to top